Open Access
Research note
Issue
Parasite
Volume 19, Number 4, November 2012
Page(s) 441 - 444
DOI https://doi.org/10.1051/parasite/2012194441
Published online 15 November 2012
  1. Ahmadi N. & Dalimi A. Characterization of Echinococcus granulosus isolates from human, sheep and camel in Iran. Infect Genet Evol, 2006, 6 (2), 85–90. [CrossRef] [PubMed]
  2. Del Brutto O.H., Rajshekhar V., White A.C. Jr., Tsang V.C., Nash T.E., Takayanagui O.M., Schantz P.M., Evans C.A., Flisser A., Correa D., Botero D., Allan J.C., Sarti E., Gonzalez A.E., Gilman R.H. & Garcia H.H. Proposed diagnostic criteria for neurocysticercosis. Neurology, 2001, 57 (2), 177–183. [CrossRef] [PubMed]
  3. Garcia H.H. Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel? Expert Rev Anti Infect Ther, 2008, 6 (3), 295–298. [CrossRef] [PubMed]
  4. Garcia H.H., Evans C.A., Nash T.E., Takayanagui O.M., White A.C. Jr., Botero D., Rajshekhar V., Tsang V.C., Schantz P.M., Allan J.C., Flisser A., Correa D., Sarti E., Friedland J.S., Martinez S.M., Gonzalez A.E., Gilman R.H. & Del Brutto O.H. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev, 2002, 15 (4), 747–756. [CrossRef] [PubMed]
  5. Garcia H.H., Gonzalez A.E., Evans C.A. & Gilman R.H. Taenia solium cysticercosis. Lancet, 2003, 362 (9383), 547–556. [CrossRef] [PubMed]
  6. Gonzalez L.M., Montero E., Harrison L.J., Parkhouse R.M. & Garate T. Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. J Clin Microbiol, 2000, 38 (2), 737–744. [PubMed]
  7. Gonzalez L.M., Montero E., Puente S., Lopez-Velez R., Hernandez M., Sciutto E., Harrison L.J., Parkhouse R.M. & Garate T. PCR tools for the differential diagnosis of Taenia saginata and Taenia solium taeniasis/cysticercosis from different geographical locations. Diagn Microbiol Infect Dis, 2002, 42 (4), 243–249. [CrossRef] [PubMed]
  8. Hawk M.W., Shahlaie K., Kim K.D. & Theis J.H. Neurocysticercosis: a review. Surg Neurol, 2005, 63 (2), 123–132; discussion 132. [CrossRef] [PubMed]
  9. Ito A., Takayanagui O.M., Sako Y., Sato M.O., Odashima N.S., Yamasaki H., Nakaya K. & Nakao M. Neurocysticercosis: clinical manifestation, neuroimaging, serology and molecular confirmation of histopathologic specimens. Southeast Asian J Trop Med Public Health, 2006, 37(Suppl. 3), 74–81. [PubMed]
  10. Lino-Junior Rde S. Faleiros A.C., Vinaud M.C., Oliveira F.A., Guimaraes J.V., Reis M.A. & Teixeira V.De.P. Anatomopathological aspects of neurocysticercosis in autopsied patients. Arq Neuropsiquiatr, 2007, 65 (1), 87–91. [CrossRef] [PubMed]
  11. Montenegro T., Gilman R.H., Castillo R., Tsang V., Brandt J., Guevara A., Sanabria H. Verastegui M., Sterling C. & Miranda E. The diagnostic importance of species specific and cross-reactive components of Taenia solium, Echinococcus granulosus, and Hymenolepis nana. Rev Inst Med Trop Sao Paulo, 1994, 36 (4), 327–334. [CrossRef] [PubMed]
  12. Sloan L., Schneider S. & Rosenblatt J. Evaluation of enzymelinked immunoassay for serological diagnosis of cysticercosis. J Clin Microbiol, 1995, 33 (12), 3124–3128. [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.